A plan to slash Food and Drug Administration drug review times is raising alarms at the public health agency that's been ...

Questions remain among top Food and Drug Administration officials over who has the appropriate legal authority to sign off on ...

All 16 drug companies that inked deals with the Trump administration over the past few months still raised some of their ...

Big pharma is grappling with new drug pricing deals and roughly $300 billion in potential lost revenue from patent expirations of blockbuster drugs.

Every January, pharmaceutical companies increase the prices of hundreds of drugs. This year there's a disconnect between the ...

The U.S. Food and Drug Administration (FDA) announced it is changing its approach to direct-to-consumer (DTC) drug advertisements after a directive from a White House Memo instructing FDA and HHS to ...

FDA leaders under President Trump are moving to abandon a decades-old policy of asking outside experts to review drug applications, a move critics say would shield the agency's decisions from public ...

"FDA and EMA release collaborative AI framework for drug development" was originally created and published by Pharmaceutical ...